NEA leads Aetion's $36.4M series B

Healthcare analytics company Aetion Inc. (New York, N.Y.) raised $36.4 million in a series B round led by NEA with participation from new investor Amgen Ventures and existing investors Flare Capital Partners, Lakestar and Oxeon Venture.

The Aetion Evidence Platform analyzes real-world data to evaluate the safety, effectiveness and value of drugs for payers and biopharma...